Is Amgen (AMGN) a Safe Bet for Income Investors in Cheap Quarterly Dividend Stocks?

Amgen Inc. (NASDAQ:AMGN) is included among the 11 Cheap Quarterly Dividend Stocks to Buy Right Now.

Is Amgen (AMGN) a Safe Bet for Income Investors in Cheap Quarterly Dividend Stocks?

Amgen Inc., a leading biotechnology company, offers investors a strong and diverse portfolio. It has more than two dozen brands, including several blockbuster drugs that each bring in over $1 billion in annual sales.

Amgen Inc.’s medicines span multiple therapeutic areas. These include Repatha, which lowers the risk of heart attacks in certain patients; Evenity and Prolia, used for bone health in postmenopausal women and cancer patients; and Otezla, a treatment for plaque psoriasis.

This broad lineup supports steady revenue and earnings growth. In the second quarter, Amgen Inc. reported revenue of $9.2 billion, up 9% from the prior year, while adjusted earnings per share rose 21% to $6.02. The company is also a solid dividend pick with 14 consecutive years of dividend growth under its belt. Currently, it offers a quarterly dividend of $2.38 per share and has a dividend yield of 3.32%, as of September 23.

READ NEXT: 10 Safest Monthly Dividend Stocks to Buy and Dividend Stock Portfolio For Retirement: 10 Stocks to Buy